Global Chlorhexidine Gluconate (CHG) Cloth Market Research Report Forecast to 2023

$4,450$6,250

Clear

Description

Chlorhexidine Gluconate (CHG) Cloth Market Information: by Product (CHG Impregnated Cloth, Others), CHG Concentration, Application, Distribution Channel, and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) — Global Forecast till 2023
Market analysis

The global chlorhexidine gluconate (CHG) cloth market is required to enroll a CAGR of 3.80% to reach USD 16,469.14 thousand till 2023. Surgical site infections (SSI) are normal surgical complexities. Chlorhexidine gluconate (CHG) materials are premoistened with an FDA-endorsed disinfectant solution for killing bacteria on the skin before the medical procedure. The wash free formula remains on the skin and is trusted by attendants to help decrease the danger of building up an SSI. Growing surgical site contaminations and a solid suggestion for the utilization of CHG items as clean operators by approved medicinal services associations have prompted the development of the global chlorhexidine gluconate (CHG) cloth market in the ongoing years. Be that as it may, symptoms of CHG items are probably going to limit global chlorhexidine gluconate (CHG) cloth market development over the conjecture time frame.

Market segmentation

Based on its product, the global chlorhexidine gluconate (CHG) cloth market, has been segmented into CHG compatible/non-impregnated cloth and CHG impregnated cloth. On the basis of its application, the global chlorhexidine gluconate (CHG) cloth market is bifurcated into personal care and surgical preparation. Based on its distribution, the global chlorhexidine gluconate (CHG) cloth market is segmented into online platforms and hospitals and retail pharmacies.

Regional analysis

Geographically, the global chlorhexidine gluconate (CHG) cloth market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Coloplast Corp (UK), Convatec (UK), Cardinal Health (US) GAMA Healthcare Ltd (UK), Medline Industries Inc. (US), Mölnlycke Health Care AB (Sweden), Becton, Dickinson and Company (US), 3M (US), Sage Products LLC (Stryker) (US), Clinicept Healthcare Ltd (UK), among others are some of the major players in the global chlorhexidine gluconate (CHG) cloth market.

Table of Contents

Table of Contents:

1 Report Prologue
2 Executive Summary
2.1 Introduction
3 Market Introduction
3.1 Scope of Study
3.2 Research Objective
3.3 List of Assumptions
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Rising surgical site infections
5.2.2 Strong recommendation for the use of CHG products as an antiseptic agent by authorized healthcare organizations
5.3 Restraints
5.3.1 Side-effects of CHG
5.4 Opportunity
5.4.1 Developing regions as a base for production
6 Market Factor Analysis
6.1 Porter’s Five Forces
6.1.1 Overview
6.1.2 Bargaining Power of Suppliers
6.1.3 Bargaining Power of Buyers
6.1.4 Threat of New Entrants
6.1.5 Threat of Substitutes
6.1.6 Intensity of Rivalry
6.2 Value Chain Analysis
6.2.1 Research & Development
6.2.2 Manufacturing
6.2.3 Distribution & Sales
6.2.4 Marketing & Sales
6.2.5 Post-Sales Monitoring
7 Global Chlorhexidine Gluconate (CHG) Cloth Market, by Product
7.1 Introduction
7.2 CHG Impregnated Cloth
7.3 CHG Compatible/Non-Impregnated Cloth
8 Global Chlorhexidine Gluconate (CHG) Cloth Market, by CHG Concentration
8.1 Introduction
8.2 2% Chlorhexidine Gluconate Cloth
8.3 4% Chlorhexidine Gluconate Cloth
9 Global Chlorhexidine Gluconate (CHG) Cloth Market, by Application
9.1 Introduction
9.2 Surgical Preparation
9.3 Personal Care
10 Global Chlorhexidine Gluconate (CHG) Cloth Market, by Distribution Channel
10.1 Introduction
10.2 Hospital & Retail Pharmacies
10.3 Online Platforms
11 Global Chlorhexidine Gluconate (CHG) Cloth Market, by Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 US
11.2.1.2 Canada
11.2.2 Latin America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 UK
11.3.1.3 France
11.3.1.4 Italy
11.3.1.5 Spain
11.3.1.6 Rest of Western Europe
11.3.2 Eastern Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest of Asia-Pacific
11.5 Middle East & Africa
11.5.1 Middle East
11.5.2 Africa
12 Competitive Landscape
12.1 Introduction
13 Company Profiles
13.1 Becton, Dickinson and Company
13.1.1 Company Overview
13.1.2 Financial Overview
13.1.3 Products/Services Offered
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.1.6 Key Strategies
13.2 3M
13.2.1 Company Overview
13.2.2 Financial Overview
13.2.3 Products/Services Offered
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.2.6 Key Strategies
13.3 Sage Products LLC (Stryker)
13.3.1 Company Overview
13.3.2 Financial Overview
13.3.3 Products/Services Offered
13.3.4 Key Developments
13.3.5 SWOT Analysis
13.3.6 Key Strategies
13.4 Clinicept Healthcare Ltd
13.4.1 Company Overview
13.4.2 Financial Overview
13.4.3 Products/Services Offered
13.4.4 Key Developments
13.4.5 SWOT Analysis
13.4.6 Key Strategies
13.5 Coloplast Corp
13.5.1 Company Overview
13.5.2 Financial Overview
13.5.3 Products/Services Offered
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.5.6 Key Strategies
13.6 Convatec
13.6.1 Company Overview
13.6.2 Financial Overview
13.6.3 Products/Services Offered
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.6.6 Key Strategies
13.7 Cardinal Health
13.7.1 Company Overview
13.7.2 Financial Overview
13.7.3 Products/Services Offered
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.7.6 Key Strategies
13.8 GAMA Healthcare Ltd
13.8.1 Company Overview
13.8.2 Financial Overview
13.8.3 Products/Services Offered
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.8.6 Key Strategies
13.9 Medline Industries Inc.
13.9.1 Company Overview
13.9.2 Financial Overview
13.9.3 Products/Services Offered
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.9.6 Key Strategies
13.1 Mölnlycke Health Care AB
13.10.1 Company Overview
13.10.2 Financial Overview
13.10.3 Products/Services Offered
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.10.6 Key Strategies
13.11 Reynard Health Supplies
13.11.1 Company Overview
13.11.2 Financial Overview
13.11.3 Products/Services Offered
13.11.4 Key Developments
13.11.5 SWOT Analysis
13.11.6 Key Strategies
14 Appendix
14.1 Discussion Blue Print

Additional information

Publisher

Geography Covered

Date Published

Pages

Format